Tinavi Medical Technologies released its 2026 interim report. Total operating revenue was 105 million yuan, down 16.00 percent year-on-year. Net profit attributable to the parent company was a loss of 70.1059 million yuan, an increase in loss of 12.5577 million yuan compared with the same period last year. Net cash flow from operating activities was negative 134 million yuan, a year-on-year decrease of 79.4274 million yuan. The company's asset-liability ratio was 27.36 percent, gross margin was 67.18 percent, down 6.49 percentage points from the same period last year, and return on equity was negative 5.88 percent. Diluted earnings per share was negative 0.15 yuan, total asset turnover was 0.06 times, and inventory turnover was 0.60 times, all down year-on-year. The number of shareholders was 17,000, and the top ten shareholders held 39.48 percent of total share capital.
Tinavi Medical Technologies Co LtdNet loss widened year-on-year with revenue down 16% and negative operating cash flow.
